Download by
Scanning QR Code
No Data
US Stock MarketDetailed Quotes
MIRO Miromatrix Medical
Watchlist
1.290
-0.020-1.53% Close 10/02 16:00 ET
1.300High1.220Low11.88KVolume
1.250Open1.310Pre Close14.85KTurnover0.06%Turnover RatioLossP/E (TTM)35.23MMarket Cap4.50052wk HighLossP/E (Static)27.31MShares0.90652wk Low1.63P/B25.30MFloat Cap16.521Historical High--Dividend TTM19.61MShs Float0.906Historical Low--Div YieldTTM6.11%Amplitude1.250Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Miromatrix Medical Company
Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. It offers perfusion decellularization and recellularization technology, as well as organ-derived biological products such as MIROMESH and MIRODERM for soft tissue reinforcement and advanced wound care. The company was founded in 2009 by Doris A. Taylor and Cohen Robert and is headquartered in Eden Prairie, MN.
News
Several Insiders Invested In Miromatrix Medical Flagging Positive News
Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference
EDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs t
Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop
EDEN PRAIRIE, Minn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs t